Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

NCT01419639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis Type II

Interventions

DRUG: Everolimus (RAD001) , Afinitor®

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]